Skip to main content

Molecular and Biological Role of CD40 in Multiple Myeloma

  • Chapter
Mechanisms in B-Cell Neoplasia 1994

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 194))

Abstract

Multiple myeloma is a progressive and fatal disease characterized by the accumulation of malignant plasma cells in the bone marrow. Although the cause of myeloma remains unknown, interleukin 6 (IL-6) has been demonstrated to be a primary growth factor for malignant plasma cells in vitro [1, 2]. Elevated levels of IL-6 in myelomatous bone marrow and a direct correlation of IL-6 levels with disease severity suggest that IL-6 may be a crucial factor for tumor expansion in vivo as well [2, 3]. At the present time, it remains uncertain, however, as to whether paracrine or autocrine sources are responsible for the significant increases in IL-6 levels that occur during disease progression (reviewed in [4]).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85

    Article  PubMed  CAS  Google Scholar 

  2. Zhang XG, Klein B, Bataille R (1989) Interleukin 6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 74: 11–13

    PubMed  CAS  Google Scholar 

  3. Bataille R, Jourdan M, Zhang XG, Klein B (1989) Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. Blood 84: 2008–2011

    CAS  Google Scholar 

  4. Mandelli F, Awisati G, Tribalto M (1992) Biology and treatment of multiple myeloma. Curr Opin Oncology 4: 73–86

    Article  CAS  Google Scholar 

  5. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T (1988) The essential role of B cell stimulating factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167: 332–344

    Article  PubMed  CAS  Google Scholar 

  6. Roldin E, Brieva JA (1991) Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: Role of bone marrow stromal cells and interleukin 6. Eur J Immunol 21: 2671–2677

    Article  Google Scholar 

  7. Splawski JB, McAnally LM, Lipsky PE (1990) IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). J Immunol 144: 562–569

    PubMed  CAS  Google Scholar 

  8. Alderson MR, Pike BL (1989) Recombinant human interleukin 6 (B cell stimulatory factor 2) enhances immunoglobulin secretion by single murine haplen-specific B cells in the absence of cell division. Intl Immunol 1: 20–28

    CAS  Google Scholar 

  9. Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR (1989) Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 169: 2133–2148

    Article  PubMed  CAS  Google Scholar 

  10. Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH (1993) Cytokine mRNA expression during an in vitro response of human B lymphocytes: Kinetics of B cell tumor necrosis factor a, interleukin (IL)6, IL-10, and transforming growth factor (3, mRNAs. J Exp Med 178: 521–528

    Article  PubMed  CAS  Google Scholar 

  11. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J (1993) Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood 81: 3357–3364

    PubMed  CAS  Google Scholar 

  12. Jelinek DF, Ahmann GJ, Greipp PR, Jalal SM, Westendorf JJ, Katzmann JA, Kyle RA, Lust JA (1993) Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: Clinical implications. Cane Res 53: 5320–5327

    CAS  Google Scholar 

  13. Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF (1994) CD40 expression in malignant plasma cells: Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 152: 117–128

    PubMed  CAS  Google Scholar 

  14. Banchereau J, Baza F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12: 881–922

    Article  PubMed  CAS  Google Scholar 

  15. Clark EA, Shu G (1990) Association between IL-6 and CD40 signaling. J Immunol 145: 1400–1406

    PubMed  CAS  Google Scholar 

  16. O’Reilly DR, Miller LK, Luckow VA (1994) Baculovirus expression vectors, a laboratory manual. Oxford University Press, New York

    Google Scholar 

  17. Brian AA (1988) Membrane isolated procedure stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc Natl Acad Sci USA 85: 564–568

    Article  PubMed  CAS  Google Scholar 

  18. Paulie S, Ehlin-Henriksson B, Mellstedt H, Kobo H, Ben-Aissa H, Perlmann P (1985) A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cane Immunol Immunother 20: 23–28

    CAS  Google Scholar 

  19. Ling NR, MacLennan ICM, Mason D (1987) B-cell and plasma cell antigens: New previously defined clusters. In: McMichael AJ (ed) Leucocyte typing III. Oxford University Press, Oxford, pp 302–335

    Google Scholar 

  20. Terstappen LWMM, Johnsen S, Segers-Nolton IMJ, Loken MR (1990) Identification and characterization of plasma cells in normal bone marrow by high-resolution flow cytometry. Blood 76: 1739–1747

    PubMed  CAS  Google Scholar 

  21. Klein B, Zhang XG, Jourdan M, Content J, Moussiau F, Aarden L, Bataille R (1989) Paracrine but not autocrine regulation of myeloma cell growth and differentiation by interleukin 6. Blood 73: 517–526

    PubMed  CAS  Google Scholar 

  22. Kyle RA, Lust JA (1989) Monoclonal gammopathies of undetermined significance. Sem Hematol 26: 176–200

    CAS  Google Scholar 

  23. Santhanum U, Ray A, Sehgal PB (1991) Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 88: 7605–7609

    Article  Google Scholar 

  24. Durie BGM (1992) Cellular and molecular genetic features of myeloma and related disorders. Hem/One Clin N Amer 6: 463–477

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Westendorf, J.J. et al. (1995). Molecular and Biological Role of CD40 in Multiple Myeloma. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1994. Current Topics in Microbiology and Immunology, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79275-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79275-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79277-9

  • Online ISBN: 978-3-642-79275-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics